Engineered Gut Bacteria Show Potential as a New Weapon Against Pancreatic CancerResearchers have developed a genetically engineered probiotic bacterium that could offer a promising new approach for treating pancreatic cancer, one of the deadliest forms of cancer with limited therapeutic options. The study demonstrates that a modified strain of Bifidobacterium longum, a naturally occurring gut bacterium, can selectively colonize pancreatic tumors and stimulate a potent anti-tumor immune response.
The engineered bacteria were designed to deliver therapeutic molecules directly within the tumor microenvironment. In preclinical studies, the treatment significantly slowed tumor growth and improved survival in mouse models. The bacteria preferentially accumulated inside pancreatic tumors while largely sparing healthy tissues, highlighting their potential as a targeted drug delivery platform.
Scientists observed that the bacterial therapy activated immune cells, including cytotoxic T cells, while reshaping the tumor microenvironment into one that was more favorable for anti-cancer immunity. This dual action, targeted delivery and immune activation, could help overcome the immune-suppressive nature of pancreatic cancer, which often limits the effectiveness of conventional immunotherapies.
The researchers believe the platform could be adapted to carry different therapeutic payloads or combined with existing cancer treatments such as immune checkpoint inhibitors, chemotherapy, or radiation therapy. While the findings are encouraging, the therapy has so far been evaluated only in laboratory and animal studies, and further research, including human clinical trials, will be required before it can be considered for routine clinical use.
Pancreatic cancer remains one of the most challenging cancers to treat, with a low five-year survival rate due to late diagnosis and resistance to many current therapies. The development of engineered probiotic bacteria offers a novel strategy that may pave the way for more precise and effective cancer treatments in the future.
